Literature DB >> 9049315

De novo telomere addition by Tetrahymena telomerase in vitro.

H Wang1, E H Blackburn.   

Abstract

Previous molecular genetic studies have shown that during programmed chromosomal healing, telomerase adds telomeric repeats directly to non-telomeric sequences in Tetrahymena, forming de novo telomeres. However, the biochemical mechanism underlying this process is not well understood. Here, we show for the first time that telomerase activity is capable in vitro of efficiently elongating completely non-telomeric DNA oligonucleotide primers, consisting of natural telomere-adjacent or random sequences, at low primer concentrations. Telomerase activity isolated from mated or vegetative cells had indistinguishable specificities for nontelomeric and telomeric primers. Consistent with in vivo results, the sequence GGGGT... was the predominant initial DNA sequence added by telomerase in vitro onto the 3' end of the non-telomeric primers. The 3' and 5' sequences of the primer both influenced the efficiency and pattern of de novo telomeric DNA addition. Priming of telomerase by double-stranded primers with overhangs of various lengths showed a requirement for a minimal 3' overhang of 20 nucleotides. With fully single-stranded non-telomeric primers, primer length up to approximately 30 nucleotides strongly affected the efficiency of telomeric DNA addition. We propose a model for the primer binding site of telomerase for non-telomeric primers to account for these length and structural requirements. We also propose that programmed de novo telomere addition in vivo is achieved through a hitherto undetected intrinsic ability of telomerase to elongate completely non-telomeric sequences.

Mesh:

Substances:

Year:  1997        PMID: 9049315      PMCID: PMC1169687          DOI: 10.1093/emboj/16.4.866

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  34 in total

1.  The Stability of Broken Ends of Chromosomes in Zea Mays.

Authors:  B McClintock
Journal:  Genetics       Date:  1941-03       Impact factor: 4.562

2.  Telomerase is processive.

Authors:  C W Greider
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

3.  The controlling sequence for site-specific chromosome breakage in Tetrahymena.

Authors:  M C Yao; C H Yao; B Monks
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

4.  Tetrahymena telomerase catalyzes nucleolytic cleavage and nonprocessive elongation.

Authors:  K Collins; C W Greider
Journal:  Genes Dev       Date:  1993-07       Impact factor: 11.361

5.  In vivo and in vitro studies of telomeres and telomerase.

Authors:  M S Lee; R C Gallagher; J Bradley; E H Blackburn
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1993

6.  Tandemly repeated hexanucleotide at Tetrahymena rDNA free end is generated from a single copy during development.

Authors:  B O King; M C Yao
Journal:  Cell       Date:  1982-11       Impact factor: 41.582

7.  De novo truncation of chromosome 16p and healing with (TTAGGG)n in the alpha-thalassemia/mental retardation syndrome (ATR-16).

Authors:  J Lamb; P C Harris; A O Wilkie; W G Wood; J G Dauwerse; D R Higgs
Journal:  Am J Hum Genet       Date:  1993-04       Impact factor: 11.025

8.  DNA sequences of telomeres maintained in yeast.

Authors:  J Shampay; J W Szostak; E H Blackburn
Journal:  Nature       Date:  1984 Jul 12-18       Impact factor: 49.962

9.  All gene-sized DNA molecules in four species of hypotrichs have the same terminal sequence and an unusual 3' terminus.

Authors:  L A Klobutcher; M T Swanton; P Donini; D M Prescott
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

10.  Tetrahymena micronuclear sequences that function as telomeres in yeast.

Authors:  J Shampay; E H Blackburn
Journal:  Nucleic Acids Res       Date:  1989-04-25       Impact factor: 16.971

View more
  44 in total

1.  Interference footprinting analysis of telomerase elongation complexes.

Authors:  S Benjamin; N Baran; H Manor
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

2.  Three telomerases with completely non-telomeric template replacements are catalytically active.

Authors:  T L Ware; H Wang; E H Blackburn
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

3.  De novo telomere addition to spacer sequences prior to their developmental degradation in Euplotes crassus.

Authors:  Matthias Möllenbeck; Lawrence A Klobutcher
Journal:  Nucleic Acids Res       Date:  2002-01-15       Impact factor: 16.971

4.  Telomerase recognizes its template by using an adjacent RNA motif.

Authors:  Michael C Miller; Kathleen Collins
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-07       Impact factor: 11.205

5.  Rapid upregulation of telomerase activity in human leukemia HL-60 cells treated with clinical doses of the DNA-damaging drug etoposide.

Authors:  T J Moriarty; S Dupuis; C Autexier
Journal:  Leukemia       Date:  2002-06       Impact factor: 11.528

6.  Studies on the minimal lengths required for DNA primers to be extended by the Tetrahymena telomerase: implications for primer positioning by the enzyme.

Authors:  Nava Baran; Yonit Haviv; Beena Paul; Haim Manor
Journal:  Nucleic Acids Res       Date:  2002-12-15       Impact factor: 16.971

7.  A human telomerase-associated nuclease.

Authors:  Rena Oulton; Lea Harrington
Journal:  Mol Biol Cell       Date:  2004-04-30       Impact factor: 4.138

Review 8.  Telomerase: an RNP enzyme synthesizes DNA.

Authors:  Elizabeth H Blackburn; Kathleen Collins
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-05-01       Impact factor: 10.005

9.  Relaxed primer specificity associated with reverse transcriptases encoded by the pFOXC retroplasmids of Fusarium oxysporum.

Authors:  E Barry Simpson; Shannon L Ross; Sarah E Marchetti; John C Kennell
Journal:  Eukaryot Cell       Date:  2004-12

10.  Biological and biochemical functions of RNA in the tetrahymena telomerase holoenzyme.

Authors:  Doreen D Cunningham; Kathleen Collins
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.